Kar, A., Zhang, Y., Yacob, B. W., Saeed, J., Tompkins, K. D., Bagby, S. M., . . . Kiseljak-Vassiliades, K. (2019). Targeting PDZ Binding Kinase Is Anti-tumorigenic in Novel Preclinical Models of ACC. Endocr Relat Cancer.
Chicago-стиль цитированияKar, Adwitiya, et al. "Targeting PDZ Binding Kinase Is Anti-tumorigenic in Novel Preclinical Models of ACC." Endocr Relat Cancer 2019.
MLA-цитированиеKar, Adwitiya, et al. "Targeting PDZ Binding Kinase Is Anti-tumorigenic in Novel Preclinical Models of ACC." Endocr Relat Cancer 2019.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.